KLF5 controls glutathione metabolism to suppress p190-BCR-ABL+ B-cell lymphoblastic leukemia

High-risk B-cell acute lymphoblastic leukemia (B-ALL) remains a therapeutic challenge despite advances in the use of tyrosine kinase inhibitors and chimeric-antigen-receptor engineered T cells. Lymphoblastic-leukemia precursors are highly sensitive to oxidative stress. KLF5 is a member of the Krüppe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Zhang, Cuiping, D'Alessandro, Angelo, Wellendorf, Ashley M., Mohmoud, Fatima, Serrano-Lopez, Juana, Perentesis, John P., Komurov, Kakajan, Alexe, Gabriela, Stegmaier, Kimberly, Whitsett, Jeffrey A., Grimes, H. Leighton, Cancelas, Jose A.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6049869/
https://ncbi.nlm.nih.gov/pubmed/30038712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25667
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados